These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35269544)

  • 1. Tracking the Molecular Fingerprint of Head and Neck Cancer for Recurrence Detection in Liquid Biopsies.
    Diez-Fraile A; De Ceulaer J; Derpoorter C; Spaas C; De Backer T; Lamoral P; Abeloos J; Lammens T
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing recurrence and new primary tumor as well as the origin of neck metastases in head and neck cancer clinical trials by targeted DNA sequencing.
    Lilja-Fischer JK; Saksø M; Stougaard M; Steiniche T; Overgaard J
    Acta Oncol; 2019 Oct; 58(10):1506-1508. PubMed ID: 31271080
    [No Abstract]   [Full Text] [Related]  

  • 3. Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN).
    Galot R; Machiels JH
    Cancer Treat Rev; 2020 Apr; 85():101992. PubMed ID: 32092618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of head neck cancer: Case for personalized and standardized surveillance.
    Mali SB
    Oral Oncol; 2023 Apr; 139():106354. PubMed ID: 36878144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC).
    Ebnoether E; Muller L
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune gene expression in head and neck squamous cell carcinoma patients.
    Lecerf C; Kamal M; Vacher S; Chemlali W; Schnitzler A; Morel C; Dubot C; Jeannot E; Meseure D; Klijanienko J; Mariani O; Borcoman E; Calugaru V; Badois N; Chilles A; Lesnik M; Krhili S; Choussy O; Hoffmann C; Piaggio E; Bieche I; Le Tourneau C
    Eur J Cancer; 2019 Nov; 121():210-223. PubMed ID: 31593831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma.
    Flach S; Howarth K; Hackinger S; Pipinikas C; Ellis P; McLay K; Marsico G; Forshew T; Walz C; Reichel CA; Gires O; Canis M; Baumeister P
    Br J Cancer; 2022 May; 126(8):1186-1195. PubMed ID: 35132238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma.
    Kogo R; Manako T; Iwaya T; Nishizuka S; Hiraki H; Sasaki Y; Idogawa M; Tokino T; Koide A; Komune N; Yasumatsu R; Nakagawa T
    Cancer Med; 2022 Nov; 11(21):3960-3968. PubMed ID: 35352507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumour DNA alterations as biomarkers for head and neck cancer: a systematic review.
    Pall AH; Jakobsen KK; Grønhøj C; von Buchwald C
    Acta Oncol; 2020 Jul; 59(7):845-850. PubMed ID: 32223478
    [No Abstract]   [Full Text] [Related]  

  • 10. Knowledge and expectations about miRNAs as biomarkers in head and neck squamous cell cancers.
    Galindo Torres BP; García Girón C; Alcaraz Ortega R; Saiz López P; Adiego Leza MI; Grijalba Uche MV
    Am J Otolaryngol; 2023; 44(2):103771. PubMed ID: 36603378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.
    Mishra V; Singh A; Chen X; Rosenberg AJ; Pearson AT; Zhavoronkov A; Savage PA; Lingen MW; Agrawal N; Izumchenko E
    Br J Cancer; 2022 Feb; 126(3):361-370. PubMed ID: 34876674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential allelic deletion of RBSP3, LIMD1 and CDC25A in head and neck squamous cell carcinoma: Implication in cancer screening and early detection.
    Sarkar S; Panda CK
    Cancer Biol Ther; 2018 Jul; 19(7):631-635. PubMed ID: 29624473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.
    Payne K; Spruce R; Beggs A; Sharma N; Kong A; Martin T; Parmar S; Praveen P; Nankivell P; Mehanna H
    Head Neck; 2018 Jul; 40(7):1598-1604. PubMed ID: 29542214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of faciogenital dysplasias as biomarkers in head and neck squamous cell carcinoma.
    Ma C; Li H; Li X; Lu S; He J
    Biomark Med; 2019 Nov; 13(16):1399-1415. PubMed ID: 31596126
    [No Abstract]   [Full Text] [Related]  

  • 17. Innovative rapid gene methylation analysis of surgical margin tissues in head and neck cancer.
    Hayashi M; Guerrero-Preston R; Okamura J; Michailidi C; Kahn Z; Li X; Ahn J; Goldsmith M; Koch W
    Ann Surg Oncol; 2014 Sep; 21(9):3124-31. PubMed ID: 24671639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings.
    Boschert V; Teusch J; Aljasem A; Schmucker P; Klenk N; Straub A; Bittrich M; Seher A; Linz C; Müller-Richter UDA; Hartmann S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring.
    Diez-Fraile A; Ceulaer J; Derpoorter C; Spaas C; Backer T; Lamoral P; Abeloos J; Lammens T
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy.
    de Roest RH; Mes SW; Poell JB; Brink A; van de Wiel MA; Bloemena E; Thai E; Poli T; Leemans CR; Brakenhoff RH
    Clin Cancer Res; 2019 Dec; 25(23):7256-7265. PubMed ID: 31439582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.